Prelude delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.
Business Model:
Revenue: $0
Employees: 11-50
Address: 26051 Merit Cir
City: Laguna Hills
State: CA
Zip: 92653
Country: US
PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from the University of California San Francisco, PreludeDx has focused on developing breast cancer tools that will impact a patient’s treatment decision. Their mission is to provide tools that improve patient outcomes in breast cancer and reduce the overall cost burden to the healthcare system.
Contact Phone:
+18882113247
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Debt | $350k |
U.S. Small Business Administration. |
7/2021 | Minority Stake | - | 3/2022 | Venture Round | $0 |
Evidity Health Capital Evidity Health Capital |
2/2016 | Venture Round | $2.1M | 7/2021 | Corporate Round | 1 | - |
GenesisCare GenesisCare |
3/2022 | Venture Round | 1 | $20M |
Evidity Health Capital Evidity Health Capital |
7/2021 | Minority Stake | - |
GenesisCare GenesisCare |
7/2021 | Corporate Round | 1 | - |
GenesisCare GenesisCare |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|